Skip to main content
. 2022 Jun 14;13:920200. doi: 10.3389/fendo.2022.920200

Table 1.

Characteristics of patients included in this study.

Characteristic Patients Value Characteristic Patients Value
Age (years) 297 10.00 ± 3.42 Hb (g/L) 296 131.30 ± 11.04
Bone age (years) 289 8.43 ± 3.83 ALT (U/L) 296 14.70 ± 8.07
Peak of GH (ng/mL) 297 7.29 ± 5.00 ALB (g/L) 296 46.88 ± 2.86
IGF-1 SDS 297 -0.60 ± 1.07 Cr (umol/L) 295 43.82 ± 11.66
IGFBP-3 (μg/mL) 293 4.55 ± 1.31 TG (mmol/L) 282 0.68 (0.53,0.91)
High SDS 297 -2.51 ± 0.53 TC (mmol/L) 282 3.91 ± 0.75
Weight (kg) 297 27.94 ± 11.91 HDL (mmol/L) 282 1.52 ± 0.41
BMI SDS 297 -0.22 ± 1.53 LDL (mmol/L) 282 2.21 ± 0.52
SMA (HU) 297 47.54 ± 4.05 Ca (mmol/L) 296 2.45 ± 0.10
T4MA (cm2) 297 94.85 ± 31.63 P (mmol/L) 296 1.60 ± 0.16
T4FA (cm2) 297 33.83 (22.57,58.23) FT3 (pmol/L) 294 6.88 ± 2.26
SMI (cm2/m2) 297 59.03 ± 8.83 FT4 (pmol/L) 294 17.90 ± 3.01
FMI (cm2/m2) 297 23.99 (15.59,37.22) TSH (mIU/L) 294 2.66 ± 1.36
TMW (kg) 205 10.88 ± 4.64 LH (mIU/ml) 281 0.23 (0.01,1.57)
TFW (kg) 205 4.90 (2.90,7.95) FSH (mIU/ml) 281 2.45 (1.05,4.36)